Fibromyalgia/Pain

Central sensitization of neuropathic pain in #PsA - patient reported outcomes. 114 pts. And 22 percent with fibromyalgia Pts with neuropathic pain didnt reach low disease activity or remission. @RheumNow #EULAR2023 highlights! https://t.co/Gxkcrruamp

Bella Mehta @bella_mehta( View Tweet )

Jun 03, 2023

Very interesting. Overweight fibromyalgia pts had some sustained benefit of their fibro on a very low calorie ketogenic diet (8 weeks ketogenic, 12 weeks carb reintroduce) Pain improvements matched weight loss. Many questions, I want to see more! POS1339 #EULAR2023 @RheumNow https://t.co/3rIPmSVUwj

David Liew @drdavidliew( View Tweet )

Jun 02, 2023

Tune it at 1pm EST for RheumNow's daily #EULAR23 recaps. You can find us live on Twitter, YouTube and LinkedIn. https://t.co/t531csjXo8

Dr. John Cush @RheumNow( View Tweet )

Jun 02, 2023

#EULAR2023 OP0083-HPR Stretch & Strength training is key! An RCT in Brazil shows: Pilates x 3/week is more effective in reducing pain, HRQoL, psychological effects & analgaesic consumption VS Aerobic walking on treadmill x 3/week for 12 weeks in women with Fibromyalgia @RheumNow https://t.co/CzIH9Xd8Ku

Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )

May 31, 2023

Colchicine and the Risk of Knee and Hip Replacement

Save

Jack Cush, MD

May 30, 2023

Treatment of osteoarthritis is a major unmet need, as there are few therapies effective at pain control and no options for disease modification; yet a new trial in Annals of Internal Medicine suggest that chronic low dose colchicine may alter disease progression and lower the risk of of total

Read Article

Orbitofrontal Cortex Implants to Assess Chronic Pain

Save

Jack Cush, MD

May 29, 2023

Nature Neuroscience reports a novel approach to assessing chronic neuropathic pain - intracranial electrodes in the anterior cingulate cortex and orbitofrontal cortex (OFC) to map chronic pain signaling.

Researchers from UCSF studied four individuals with refractory

Read Article

Save the date! We'll be tuning in live from Milan for EULAR '23. Count on us for: -KOL perspective videos -Clinical Trial Highlights -Daily Faculty Recaps -Live Streaming and more! https://t.co/9uKnDTynfk

Dr. John Cush @RheumNow( View Tweet )

May 29, 2023

3-4-5 Rule (5.26.2023)

Save

Jack Cush, MD

May 26, 2023

Dr. Jack Cush reviews more than a dozen news, journal articles and RNL highlights from this past week on RheumNow.com.

Read Article

The Burden of Chronic Pain in US Adults (2019-2020) Analysis of National Health Interview Survey data shows that the incidence of chronic pain in the USA is high compared with other chronic diseases. https://t.co/mH6Zb3i3Vw https://t.co/PWI8R6mKJR

Links:

https://bit.ly/45HAJkm

Dr. John Cush @RheumNow( View Tweet )

May 25, 2023

Falls with Knee Osteoarthritis

Save

Jack Cush, MD

May 24, 2023

A study of adults aged 45-85 yrs shows that knee osteoarthritis (OA) is an independent risk factor for falls, suggesting a greater need for awareness and prevention.

Data were derived from a 3 year Canadian Longitudinal (Survey) Study on Aging examing those with reported knee OA or no

Read Article

NSAID Prescribing Decreasing

Save

Jack Cush, MD

May 24, 2023

Multinational metanalyses of data between 1989 and 2022 shows that NSAID prescriptions have decreased over time, and differs according to geographical locations.

This systematic review looked at osteoarthritis patients and non-steroidal anti-inflammatory drugs (NSAIDs) use. A total of

Read Article

The Burden of Chronic Pain in US Adults (2019-2020)

Save

Jack Cush, MD

May 23, 2023

Analysis of National Health Interview Survey data shows that the incidence of chronic pain in the USA is high compared with other chronic diseases.

A US population based cohort analysis using the 2019-2020 National Health Interview Survey (NHIS) Longitudinal Cohort data looked at

Read Article

Cochrane metanalysis of antidepressant use in managing chronic pain shows they dont work, with the small exception, duloxetine - at standard dose (60 mg) it was effective, but no benefit to using a higher doses https://t.co/SReueTu4VV https://t.co/ki0snBMS3z

Links:

https://bit.ly/433wGwT

Dr. John Cush @RheumNow( View Tweet )

May 22, 2023

RELIEF Trial: Sublingual Cyclobenzaprine in Fibromyalgia https://t.co/a6KUPcfmxM https://t.co/ToRJQVsZSu

Links:

https://bit.ly/42HVhXS

Dr. John Cush @RheumNow( View Tweet )

May 18, 2023

RELIEF Trial: Sublingual Cyclobenzaprine in Fibromyalgia

Save

MedPage Today

May 16, 2023

Fibromyalgia patients hoping to see a more effective and convenient formulation of cyclobenzaprine at their local pharmacies must wait for an ongoing phase III trial -- the product's third -- to finish, as the first two delivered mixed results.

Read Article

Have a Rheumatology question or case for Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/0mC7PxF0DU https://t.co/klbnwjcPbM

Links:

https://bit.ly/44RqwkX

Dr. John Cush @RheumNow( View Tweet )

May 10, 2023

Clinical overview of subacromial pain syndr (SAPS) Brit J Sports Med. SAPS has heterogeneous causes; Dx by physical examination and imaging. Need to exclude glenohumeral OA, frozen shoulder, GH instability, rotator cuff tears, neuro & cervical disorders https://t.co/d77kXa2qSi https://t.co/vBF0692huh

Links:

https://bit.ly/3M4XpTR

Dr. John Cush @RheumNow( View Tweet )

May 08, 2023

Prospective study.of 370 #FM pts (79% F; age 34yrs), and 79% were female w/ 14.3 tender points. A delay in Dx was signif correlated wtih Sx Severity Scale (r = 0.14) & tender points (r = 0.16), but not widespread pain. Early Dx = less severe FM. https://t.co/tvl0rkREHe https://t.co/OduJ3cq4Jg

Links:

https://bit.ly/41WaFPI

Dr. John Cush @RheumNow( View Tweet )

Apr 28, 2023

Join us 4/25 as we conclude our Women in Rheumatology campaign by focusing on what's next. Our panelists will recap the challenges addressed this month and discuss a strategy to suppot women in rheumatology. https://t.co/DP4S2hf5Tz @uptoTate @KDAO2011 @gwenesta_melton https://t.co/rcglaZxqoF

Links:

https://bit.ly/3H3v3WX

Dr. John Cush @RheumNow( View Tweet )

Apr 21, 2023

TNR: Private Practice & Academia In this session, our panelists addressed the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?". https://t.co/yMJ5mCtSXX @KDAO2011 https://t.co/eeFYkLYsAh

Links:

https://bit.ly/3ozQusd

Dr. John Cush @RheumNow( View Tweet )

Apr 21, 2023

Study of 9558 pts found significant associations betw migraine and CTS Median nerve decompression (OR, 1.3) & multiple nerve decompressions (OR, 1.7). Also assoc w/ migraine: psych dz, RA, CVS, hypothyroid, HTN, COPD https://t.co/cIdkACHGwB https://t.co/VO3VqujzSQ

Links:

https://bit.ly/3A5khf3

Dr. John Cush @RheumNow( View Tweet )

Apr 18, 2023

Pain and Opioid Updates The CDC and FDA provided new updates on the scope of pain in the USA and guidance on the use of opioids. https://t.co/jjN9zvX7rV https://t.co/kY3kX1S8vq

Links:

https://bit.ly/3A497XV

Dr. John Cush @RheumNow( View Tweet )

Apr 17, 2023

Join us April 18 for: Private Practice & Academia In this session, our panelists will address the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?". https://t.co/BrWG57mRRG https://t.co/A0pzEvJ3cu

Links:

https://bit.ly/3UzGT0y

Dr. John Cush @RheumNow( View Tweet )

Apr 14, 2023

Pain and Opioid Updates

Save

Jack Cush, MD

Apr 13, 2023

Today, the CDC and FDA provided new updates on the scope of pain in the USA and guidance on the use of opioids.

MMWR April 14, 2023

Read Article

Dr. Megan Clowse discusses the differences in pregnancy planning for men and women with rheumatic disease, with particular focus on medication use. Watch now. https://t.co/Ine8CdbZR4 https://t.co/7UnanlnQcC

Links:

https://bit.ly/3Kod7r1

Dr. John Cush @RheumNow( View Tweet )

Apr 12, 2023

Recent Blogs

From the Archives: Rheumatology Dead Word Cemetery

Save

Jack Cush, MD

Oct 31, 2022

I recently heard of a secondary school assignment wherein students were challenged to “bury” a word that was no longer useful or appropriate. Their exercise has now evolved into an unofficial RheumNow task force to retire diagnostic terms that have grown into misuse in rheumatology and medicine. How did we decide which words should perish? And by what criteria? Who has the final say? Read Post